Correlation Between Quisitive Technology and Rakovina Therapeutics
Can any of the company-specific risk be diversified away by investing in both Quisitive Technology and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quisitive Technology and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quisitive Technology Solutions and Rakovina Therapeutics, you can compare the effects of market volatilities on Quisitive Technology and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quisitive Technology with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quisitive Technology and Rakovina Therapeutics.
Diversification Opportunities for Quisitive Technology and Rakovina Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Quisitive and Rakovina is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Quisitive Technology Solutions and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and Quisitive Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quisitive Technology Solutions are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of Quisitive Technology i.e., Quisitive Technology and Rakovina Therapeutics go up and down completely randomly.
Pair Corralation between Quisitive Technology and Rakovina Therapeutics
Assuming the 90 days trading horizon Quisitive Technology Solutions is expected to generate 0.55 times more return on investment than Rakovina Therapeutics. However, Quisitive Technology Solutions is 1.82 times less risky than Rakovina Therapeutics. It trades about -0.07 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about -0.24 per unit of risk. If you would invest 39.00 in Quisitive Technology Solutions on August 27, 2024 and sell it today you would lose (2.00) from holding Quisitive Technology Solutions or give up 5.13% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Quisitive Technology Solutions vs. Rakovina Therapeutics
Performance |
Timeline |
Quisitive Technology |
Rakovina Therapeutics |
Quisitive Technology and Rakovina Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Quisitive Technology and Rakovina Therapeutics
The main advantage of trading using opposite Quisitive Technology and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quisitive Technology position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.Quisitive Technology vs. Telus Corp | Quisitive Technology vs. Toronto Dominion Bank | Quisitive Technology vs. Manulife Financial Corp | Quisitive Technology vs. Canadian Natural Resources |
Rakovina Therapeutics vs. Converge Technology Solutions | Rakovina Therapeutics vs. Ocumetics Technology Corp | Rakovina Therapeutics vs. Broadcom | Rakovina Therapeutics vs. Quisitive Technology Solutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |